Endothelin-1 levels in chronic congestive heart failure

Wiener Klinische Wochenschrift

Volumn 123, Issue 23-24, 2011, Pages 714-717

  Ohmae, Minoru ^a  

^a Kochi General Rehabilitation Hospital   (Japan)

Author keywords

BNP; Chronic congestive heart failure with preserved ejection fraction; Endothelin 1; HANP; Left ventricular ejection fraction

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; ENDOTHELIN 1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; HUMAN TISSUE; MALE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; ENDOTHELIN-1; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84856977378     PISSN: 00435325     EISSN: 16137671     Source Type: Journal    
DOI: 10.1007/s00508-011-0097-6     Document Type: Article

References (21)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5. (Pubitemid 18090241)
2. Shichiri M, Hirata Y, Ando K, et al. Plasma endothelin levels in hypertension and chronic renal failure. Hypertension 1990;15:493-6. (Pubitemid 20148040)
3. Wei CM, Lerman A, Rodeheffer RJ, et al. Endothelin in heart failure. Circulation 1994;89:1580-6.
4. Yazici M, Demircan S, Durna K, Sahin M. The relation between endothelin-1 levels and myocardial injury in chronic ischemic heart failure. Heart Vessels 2005;20:95-9. (Pubitemid 40778841)
5. Tsuji T, Masuda H, Imagawa K, et al. Stability of human atrial natriuretic peptide in blood samples. Cli Chim Acta 1994;225:171-7. (Pubitemid 24159170)
6. Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. J Clin Invest 1991;87:1402-12.
7. Suzuki N, Masumoto H, Kitada C, et al. A sensitive sandwichenzyme immunoassay for human endothelin. J Immunol Methods 1989;31:245-50. (Pubitemid 19082052)
8. Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006;355:251-9. (Pubitemid 44079340)
9. Ladeiras-Lopes R, Ferreira-Martins J, Leite-Moreira AF. Acute neurohumoral modulation of diastolic function. Peptides 2009;30:419-25.
10. Brown RD, Ambler SK, Mitchell MD, Long CS. The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol 2005;45:657-87. (Pubitemid 40261821)
11. Prefontaine A, Calderone A, Dupuis J. Downregulation of the endothelin system of lung myofibroblasts in congestive heart failure. J Cardiovasc Pharmacol 2009;54:147-53.
12. Groenning BA, Nilsson JC, Sondergaard L, et al. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations. Eur J Heart Fail 2001;3:699-708. (Pubitemid 33121347)
13. Emori T, Hirata Y, Imai T, et al. Cellular mechanism of natriuretic peptides-induced inhibition of endothelin-1 biosynthesis in rat endothelial cells. Endocrinology 1993;133:2474-80. (Pubitemid 24000691)
14. Fukuda Y, Hirata Y, Taketani S, et al. Endothelin stimulates accumulations of cellular atrial natriuretic peptide and its messenger RNA in rat cardiocytes. Biochem Biophys Res Commun 1989;164:1431-6. (Pubitemid 19284005)
15. McMurray JJ, Ray SG, Abdullah I, Dargie HJ, Morton JJ. Plasma endothelin in chronic heart failure. Circulation 1992;85:1374-9.
16. Glenn DJ, Wang F, Chen S, Nishimoto M, Gardner DG. Endothelin-stimulated human B-type natriuretic peptide gene expression is mediated by Yin Yang 1 in association with histone deacetylase 2. Hypertension 2009;53:549-55.
17. Katayama T, Yano K, Nakashima H, et al. Clinical significance of acute-phase endothelin-1 in acute myocardial infarction patients treated with direct coronary angioplasty. Circ J 2005;69:654-8. (Pubitemid 40806102)
18. Suzuki E, Hirata Y, Kohmoto O, et al. Cellular mechanisms for synthesis and secretion of atrial natriuretic peptide and brain natriuretic peptide in cultured rat atrial cells. Circ Res 1992;71:1039-48.
19. Nakagawa Y, Kuwahara K, Harada M, et al. Class II HDACs mediate CaMK-dependent signaling to NRSF in ventricular myocytes. J Mol Cell Cardiol 2006;41:1010-22. (Pubitemid 44802867)
20. Rehsia NS, Dhalla NS. Potential of endothelin-1 and vasopressin antagonists for the treatment of congestive heart failure. Heart Fail Rev 2010;15:85-101.
21. Albrecht C, Hulsmann M, Strunk G, et al. Prognostic value of plasma midregional pro-adrenomedullin and C-terminalpro-endothelin-1 in chronic heart failure outpatients. Eur J Heart Fail 2009;11:361-6.